Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity

Oral Oncology

Volumn 45, Issue 6, 2009, Pages 505-510

  Chen, Wen Cheng ^a,b   Hwang, Tzer Zen ^c   Wang, Wen Hung ^a   Lu, Chang Hsien ^a   Chen, Chih Cheng ^a   Chen, Chien Ming ^a   Weng, Hsu Huei ^a,b,e   Lai, Chia Hsuan ^a   Chen, Miao Fen ^a,b,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Conventional radiotherapy; Intensity modulated radiotherapy; Oral cancer; Stage III IV; Toxicity

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; PRIORITY JOURNAL; SKIN TOXICITY; TOXICITY; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; XEROSTOMIA;

EID: 67349262012     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.07.002     Document Type: Article

References (31)

1. Bloom N.D., and Spiro R.H. Carcinoma of the cheek mucosa. A retrospective analysis. Am J Surg 140 (1980) 556-559
2. Looser K.G., Shah J.P., and Strong E.W. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg 1 (1978) 107-111
3. Huang D.T., Johnson C.R., Schmidt-Ullrich R., and Grimes M. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys 23 (1992) 737-742
4. Olsen K.D., Caruso M., Foote R.L., et al. Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg 120 (1994) 1370-1374
5. Urist M.M., O'Brien C.J., Soong S.J., Visscher D.W., and Maddox W.A. Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors. Am J Surg 154 (1987) 411-414
6. Zelefsky M.J., Harrison L.B., Fass D.E., Armstrong J.G., Shah J.P., and Strong E.W. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 25 (1993) 17-21
7. Amdur R.J., Parsons J.T., Mendenhall W.M., Million R.R., Stringer S.P., and Cassisi N.J. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 16 (1989) 25-36
8. Chen T.Y., Emrich L.J., and Driscoll D.L. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys 13 (1987) 833-837
9. Mantravadi R.V., Haas R.E., Liebner E.J., Skolnik E.M., and Applebaum E.L. Postoperative radiotherapy for persistent tumor at the surgical margin in head and neck cancers. Laryngoscope 93 (1983) 1337-1340
10. Vikram B., Strong E.W., Shah J.P., and Spiro R. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 6 (1984) 720-723
11. Peters L.J., Goepfert H., Ang K.K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26 (1993) 3-11
12. Ang K.K., Trotti A., Brown B.W., et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51 (2001) 571-578
13. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New Engl J Med 350 (2004) 1937-1944
14. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New Engl J Med 350 (2004) 1945-1952
15. Wu Q., Manning M., Schmidt-Ullrich R., and Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 46 (2000) 195-205
16. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
17. Byers R.M., Clayman G.L., Guillamondequi O.M., Peters L.J., and Goepfert H. Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract. Head Neck 14 (1992) 133-138
18. Som P.M., Curtin H.D., and Mancuso A.A. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg 125 (1999) 388-396
19. Gregoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
20. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
21. Kaplan EL M.P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 53 (1958) 457-481
22. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
23. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
24. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10 (1987) 19-30
25. Langendijk J.A., Slotman B.J., van der Waal I., Doornaert P., Berkof J., and Leemans C.R. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 104 (2005) 1408-1417
26. Leon X., Lopez M., Pineiro Z., Langendijk J.A., Leemans C.R., and Quer M. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck 29 (2007) 815-821
27. Yao M., Chang K., Funk G.F., et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the University of Iowa experience. Int J Radiat Oncol Biol Phys 67 (2007) 1332-1341
28. Chao K.S., Ozyigit G., Blanco A.I., et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 59 (2004) 43-50
29. Daly M.E., Lieskovsky Y., Pawlicki T., et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 29 (2007) 211-220
30. Rades D., Fehlauer F., Wroblesky J., Albers D., Schild S.E., and Schmidt R. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol 43 (2007) 535-543
31. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31 (1995) 1049-1091